Related Experiment Video
Updated: May 11, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Primary glomerulonephritis in mainland China: an overview
1Nephrology Department, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China.
Primary glomerulonephritis (GN) is a leading cause of chronic kidney disease (CKD) in China. This review examines the prevalence, causes, features, and treatment of GN in China, highlighting genetic factors and limited treatment evidence.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- Chronic kidney disease (CKD) is a growing global health concern with significant costs.
- Primary glomerulonephritis (GN) is the primary driver of CKD and end-stage renal disease in China.
- Immunoglobulin A nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS) are prevalent forms of GN in China, with familial cases suggesting genetic involvement.
Purpose of the Study:
- To review the current epidemiology, etiology, clinicopathological characteristics, and treatment strategies for primary GN in China.
- To highlight the increasing prevalence of membranous nephropathy and the role of genetics in FSGS and IgAN.
- To discuss the challenges in evidence-based treatment and adherence to international guidelines like KDIGO.
Main Methods:
- Literature review of current research on primary glomerulonephritis in China.
- Analysis of epidemiological data on the incidence and prevalence of different GN types.
- Examination of clinicopathological features and etiological factors, including genetic predispositions.
- Review of current treatment practices and adherence to KDIGO guidelines.
Main Results:
- Primary GN is the leading cause of CKD in China, with IgAN being the most common type.
- Prevalence of FSGS varies regionally, and membranous nephropathy is increasing.
- Genetic factors are implicated in familial FSGS and IgAN.
- Treatment evidence for primary GN is limited, with most practitioners following KDIGO guidelines.
Conclusions:
- Primary GN poses a significant health challenge in China, necessitating further research into its pathogenesis and treatment.
- Understanding regional variations and genetic factors is crucial for managing GN effectively.
- Adherence to international guidelines is common, but the lack of specific evidence poses treatment challenges.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Nephrotic Syndrome I : Introduction
Chronic Pancreatitis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Chronic Kidney Disease I: Introduction
